29171000087106: NUVAXOVID recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Vaccine product\vaccin contre le coronavirus 2 du syndrome respiratoire aigu sévère (produit médicinal)\SARS-CoV-2 antigen vaccine\COVID-19 recombinant spike protein unspecified\COVID-19 NUVAXOVID NOV
\Vaccine product\Virus antigen-containing vaccine product\SARS-CoV-2 antigen vaccine\COVID-19 recombinant spike protein unspecified\COVID-19 NUVAXOVID NOV

\Product manufactured as parenteral dose form (product)\COVID-19 NUVAXOVID NOV

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

150161000087119 COVID-19 NOVAVAX COVID-19 VACCINE NOV en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

150171000087111 COVID-19 VACCIN NOVAVAX CONTRE LA COVID-19 NOV fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)

172551000087110 COVID-19 NUVAXOVID NOV en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

172571000087116 NUVAXOVID recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

172581000087119 NUVAXOVID recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

172591000087117 NUVAXOVID protein subunit 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

173911000087111 COVID-19 NUVAXOVID NVX-CoV2373 5 mcg/0.5 ml vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
COVID-19 NUVAXOVID NOV	est un(e) (attribut)	Product manufactured as parenteral dose form (product)	true	Inferred relationship	Some
COVID-19 NUVAXOVID NOV	a une forme pharmaceutique (attribut)	forme pharmaceutique pour usage parentéral (forme pharmaceutique)	true	Inferred relationship	Some
COVID-19 NUVAXOVID NOV	est un(e) (attribut)	COVID-19 recombinant spike protein unspecified	true	Inferred relationship	Some
COVID-19 NUVAXOVID NOV	Plays role	Active immunity stimulant role (role)	true	Inferred relationship	Some
COVID-19 NUVAXOVID NOV	a pour principe actif (attribut)	antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance)	true	Inferred relationship	Some	1
COVID-19 NUVAXOVID NOV	Has supplier	Novavax Inc. (supplier)	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Administered tradename codes for vaccines reference set (foundation metadata concept)

Description inactivation indicator reference set